<DOC>
	<DOCNO>NCT01056497</DOCNO>
	<brief_summary>Chronically elevate free fatty acid impair insulin sensitivity insulin secretion ( ie lipotoxicity ) combination oxidative stress , endoplasmic reticulum ( ER ) stress inflammation . This study test whether alpha-lipoic acid , potent antioxidant anti-inflammatory property , prevents ameliorate lipotoxicity .</brief_summary>
	<brief_title>The Effect A-lipoic Acid ( ALA ) Fatty Acid-induced Impairment Glucose-stimulated Insulin Secretion</brief_title>
	<detailed_description>Alpha-Lipoic Acid ( ALA ) naturally occur dithiol compound absorb intact dietary source synthesize enzymatically mitochondrion octanoic acid . It serve critical role mitochondrial energy metabolism potent biological antioxidant . It widely available over-the-counter health supplement . It generate considerable interest among lay public research community use ALA nutritive supplement pharmacotherapy diabetes many disorder . There grow evidence ALA beneficial effect treatment type 2 diabetes ( T2DM ) complication . It represent attractive pharmacological target treatment T2DM modulate signal transduction pathway insulin resistance antagonize oxidative inflammatory stress , major pathway pathogenesis disorder . Chronic elevation plasma FFAs believe contribute insulin resistance defect insulin secretion promote oxidative stress inflammation . A potent antioxidant free radical scavenger , ALA also target cellular signal transduction pathway , increase glucose uptake utilization , thus provide specific targeted therapy treatment insulin resistance . ALA show safe take high dos ( 2400mg/d ) prolong time period ( 6 month longer ) , even patient renal liver failure . In fact upper limit ALA consumption human establish . - Each subject undergo 4 study , 4 6 week apart . Each study consist 2 week treatment period either oral ALA tablet placebo tablet , follow 30 hour hospital stay infuse lipid saline test insulin sensitivity insulin secretion . - The study conduct single blind study , subject know whether receive placebo ALA. For safety reason since influence result study conduct double blind study . - On four occasion , 4 week apart , take tablet 2 week , subject fast overnight 12-hours prior admission Toronto General Hospital metabolic research ward 30 hour undergo test follow . The four study conduct random order :</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Men woman age 2065 year : 1 . Written inform consent obtain 2 . Body mass index ( BMI ) &gt; 27kg/m2 3 . Glucose tolerance test may normal demonstrate impaired glucose tolerance frank diabetes 4 . Hemoglobin 130g/L 1 . Subject history hepatitis/hepatic disease active within previous two year 2 . Any significant active ( past 12 month ) disease gastrointestinal , pulmonary , neurological , renal ( Cr &gt; 1.5 mg/dL ) genitourinary , hematological system , severe uncontrolled treated untreated hypertension ( sit diastolic BP &gt; 100 systolic &gt; 180 ) proliferative retinopathy 3 . Type 2 diabetes history OGTT 4 . Any history MI clinically significant , active , cardiovascular history include history arrhythmia 's conduction delay ECG , unstable angina , decompensated heart failure 5 . Any laboratory value : AST &gt; 2x ULN ; ALT &gt; 2x ULN ; TSH &gt; 6 mU/l 6 . A history multiple and/or severe allergy drug food history severe anaphylactic reaction . History hypersensitivity heparin 7 . Current addiction alcohol substance abuse determine investigator 8 . Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation 9 . Any lipid lowering hypoglycemic agent 10 . Previous history asthma 11 . Will donate blood three month prior three month post study procedures 12 . Thrombocytopenia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>alpha lipoic acid</keyword>
	<keyword>endoplasmic reticulum ( ER ) stress</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>insulin sensitivity</keyword>
</DOC>